Browsing by Author Pentheroudakis, G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 24 to 43 of 104 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-upPacini, F.; Castagna, M. G.; Brilli, L.; Pentheroudakis, G.24-Nov-2015-
Disseminated intravascular coagulation (DIC) and non-small cell lung cancer (NSCLC): report of a case and review of the literatureVoulgaris, E.; Pentheroudakis, G.; Vassou, A.; Pavlidis, N.24-Nov-2015-
Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II studyPentheroudakis, G.; Briasoulis, E.; Kalofonos, H. P.; Fountzilas, G.; Economopoulos, T.; Samelis, G.; Koutras, A.; Karina, M.; Xiros, N.; Samantas, E.; Bamias, A.; Pavlidis, N.24-Nov-2015-
Docetaxel-induced enterocolitis: a serious and potentially fatal adverse eventBoussios, S.; Pentheroudakis, G.; Kamina, S.; Katsanos, K.; Pavlidis, N.24-Nov-2015-
Donor-derived breast cancer in a bone marrow transplantation recipientGolfinopoulos, V.; Pentheroudakis, G.; Kamakari, S.; Metaxa-Mariatou, V.; Pavlidis, N.24-Nov-2015-
Elderly patients with squamous lung carcinoma: faring better or worse?Pentheroudakis, G.; Neanidis, K.; Kostadima, L.; Fountzilas, G.; Pavlidis, N.24-Nov-2015-
Gastrointestinal, urologic and lung malignancies during pregnancyPentheroudakis, G.; Pavlidis, N.24-Nov-2015-
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trialPentheroudakis, G.; Kalogeras, K. T.; Wirtz, R. M.; Grimani, I.; Zografos, G.; Gogas, H.; Stropp, U.; Pectasides, D.; Skarlos, D.; Hennig, G.; Samantas, E.; Bafaloukos, D.; Papakostas, P.; Kalofonos, H. P.; Pavlidis, N.; Fountzilas, G.24-Nov-2015-
Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target?Dova, L.; Pentheroudakis, G.; Georgiou, I.; Malamou-Mitsi, V.; Vartholomatos, G.; Fountzilas, G.; Kolaitis, N.; Kitsiou, E.; Pavlidis, N.24-Nov-2015-
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapyFountzilas, G.; Valavanis, C.; Kotoula, V.; Eleftheraki, A. G.; Kalogeras, K. T.; Tzaida, O.; Batistatou, A.; Kronenwett, R.; Wirtz, R. M.; Bobos, M.; Timotheadou, E.; Soupos, N.; Pentheroudakis, G.; Gogas, H.; Vlachodimitropoulos, D.; Polychronidou, G.; Aravantinos, G.; Koutras, A.; Christodoulou, C.; Pectasides, D.; Arapantoni, P.24-Nov-2015-
Heterogeneity in cancer guidelines: should we eradicate or tolerate?Pentheroudakis, G.; Stahel, R.; Hansen, H.; Pavlidis, N.24-Nov-2015-
High levels of topoisomerase IIalpha protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatmentPentheroudakis, G.; Goussia, A.; Voulgaris, E.; Nikolaidis, K.; Ioannidou, E.; Papoudou-Bai, A.; Grepi, K.; Kanavaros, P.; Pavlidis, N.; Bai, M.24-Nov-2015-
High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upStupp, R.; Tonn, J. C.; Brada, M.; Pentheroudakis, G.24-Nov-2015-
Immunohistochemical expression of DNA topoisomerase IIalpha in diffuse large B-cell lymphomasPapoudou-Bai, A.; Ioannidou, E.; Goussia, A.; Lambri, E.; Pentheroudakis, G.; Pavlidis, N.; Malamou-Mitsi, V.; Kanavaros, P.; Bai, M.24-Nov-2015-
Immunohistochemical Profiling of Signalling Pathways in Cancer of Unknown Primary (CUP)Pentheroudakis, G.; Petrakis, D.; Goussia, A.; Siozopoulou, V.; Bobos, M.; Fountzilas, G.; Cervantes, A.; Malamou-Mitsi, V.; Ciuleanu, T.; Pavlidis, N.24-Nov-2015-
Immunomodulation in colorectal cancer: disappointment or promise?Pentheroudakis, G.; Pavlidis, N.24-Nov-2015-
Improved prognosis of patients with intermediate- and poor-risk nonseminomatous germ cell tumours by optimizing combined treatmentPentheroudakis, G.; De Bono, J. S.; Kaye, S. B.; Simpson, A.; Paul, J.; Brown, I.; Pamenter, B.; Kirk, A.; Vasey, P.; Raby, N.; Kirk, D.24-Nov-2015-
Incorporation of targeted agents in the management of patients with advanced gastric cancerPentheroudakis, G.; Stoyianni, A.24-Nov-2015-
Inflammatory prostate cancer: an underestimated paraneoplastic clinical manifestationMauri, D.; Pentheroudakis, G.; Tolis, C.; Chojnacka, M.; Pavlidis, N.24-Nov-2015-
Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: accumulating evidence of efficacy, synergy and safetyLazaridis, G.; Pentheroudakis, G.; Pavlidis, N.24-Nov-2015-